Appotype

Appotype was hired by Braster S.A., a medical devices company, to upgrade their iOS app used by individuals at home and in medical facilities. The project, which ran from March to May 2023, involved a week of testing and was completed by a team of 2-3 people. The CEO of Braster S.A. reported that Appotype had previously developed their Android and iOS apps and was chosen for this project based on a recommendation. The total investment for the project was under €5,000 (approximately $5,400 USD).

In another project, Appotype partnered with Angelini Pharma Polska Sp. z o.o, a Polish department of an Italian company specializing in the manufacture and distribution of medicinal products. The goal was to develop a mobile and web application as an educational platform for doctors. Appotype designed and implemented the platform, which included a mobile app, a web app, and a website. The project encompassed a full range of work, from requirements gathering, design, implementation, and post-implementation support. The team of 2-5 employees was chosen due to their high ratings, budget-friendly pricing, good value for cost, and company values.

In a third project, Appotype collaborated with a multinational company to build custom AI-driven software solutions. The project involved the development of a web app, mobile apps, interactive surfaces, and additional digital interfaces powered by custom AI models. Appotype played a crucial role in transforming the company's AI vision into a fully functional ecosystem, by developing custom AI models tailored to the industry’s unique needs, building a web and mobile application, implementing interactive AI-powered surfaces and interfaces, creating a scalable backend system, and providing AI consulting. The team of 6-10 employees was chosen due to their high ratings, budget-friendly pricing, good value for cost, and company values.